These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 11110735)

  • 1. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.
    Mogensen CE; Neldam S; Tikkanen I; Oren S; Viskoper R; Watts RW; Cooper ME
    BMJ; 2000 Dec; 321(7274):1440-4. PubMed ID: 11110735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
    Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
    Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT; O'Kane KP; Istad H; Keinänen-Kiukaanniemi S; Van Mierlo HF
    J Hum Hypertens; 2000 Apr; 14(4):263-9. PubMed ID: 10805052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design.
    Andersen NH; Knudsen ST; Poulsen PL; Poulsen SH; Helleberg K; Eiskjaer H; Hansen KW; Bek T; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):96-9. PubMed ID: 12806591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
    Sengul AM; Altuntas Y; Kürklü A; Aydin L
    Diabetes Res Clin Pract; 2006 Feb; 71(2):210-9. PubMed ID: 16112244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy].
    Philips JC; Weekers L; Scheen AJ
    Rev Med Liege; 2001 Feb; 56(2):126-8. PubMed ID: 11294048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.
    Hajjar I; Okafor M; McDaniel D; Obideen M; Dee E; Shokouhi M; Quyyumi AA; Levey A; Goldstein F
    JAMA Netw Open; 2020 Aug; 3(8):e2012252. PubMed ID: 32761160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
    Fogari R; Corradi L; Zoppi A; Lazzari P; Mugellini A; Preti P; Rinaldi A
    Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.
    Schram MT; van Ittersum FJ; Spoelstra-de Man A; van Dijk RA; Schalkwijk CG; Ijzerman RG; Twisk JW; Stehouwer CD
    J Hum Hypertens; 2005 Jun; 19(6):429-37. PubMed ID: 15647778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.
    Izzo JL; Weinberg MS; Hainer JW; Kerkering J; Tou CK;
    J Clin Hypertens (Greenwich); 2004 Sep; 6(9):485-93. PubMed ID: 15365275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
    Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.
    Andersen NH; Poulsen PL; Knudsen ST; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Mogensen CE
    Diabetes Care; 2005 Feb; 28(2):273-7. PubMed ID: 15677778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients.
    Hirschl MM; Bur A; Woisetschlaeger C; Derhaschnig U; Laggner AN
    J Clin Hypertens (Greenwich); 2007 Jun; 9(6):430-5. PubMed ID: 17541328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril.
    Black HR; Graff A; Shute D; Stoltz R; Ruff D; Levine J; Shi Y; Mallows S
    J Hum Hypertens; 1997 Aug; 11(8):483-9. PubMed ID: 9322828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Rosei EA; Rizzoni D; Muiesan ML; Sleiman I; Salvetti M; Monteduro C; Porteri E;
    J Hypertens; 2005 Feb; 23(2):435-44. PubMed ID: 15662233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K; Christensen PK; Jensen BR; Parving HH
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.